Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease Health Condition 2: E118- Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients within 30 to 80 years old. Patient having both diabetes and hyperuricemia. Patient with FBS greater than 150mg per dl.
Exclusion criteria
Exclusion criteria: Patients with type 1 diabetes mellitus or other types of diabetes. 2. Patients with secondary causes of hyperuricemia (cancer, or use of certain medications). . 3. Patients with severe comorbidities or complications that may interfere with the study outcomes (e.g., end-stage renal disease, liver failure, or severe cardiovascular disease). 4. Patients receiving systemic corticosteroid therapy or other immunosuppressive medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. changes in fasting blood glucose level 2. changes in serum uric acid levelTimepoint: 1. changes in fasting blood glucose level will be checked after 6 months of giving medicines 2. changes in serum uric acid level will be checked after 6 months of giving medicines total duration of study is 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Government homoeopathic medical college